Medical disclaimer. This page is for tracking and education only. It is not medical advice and it never recommends doses. Talk with your prescriber or care team before you change, lower, or stop any medication. Ozempic, Wegovy, Mounjaro, and Zepbound are named only to describe what readers search for.
A GLP 1 taper schedule is something to track, not something this site creates. The app will let you record the steps your prescriber gave you, along with notes, so you can keep the plan in one place without guessing or making changes yourself.
Why there is no schedule on this site
This site does not publish a glp1 taper schedule because the FDA prescribing information for Wegovy and Zepbound does not give a dose taper schedule for stopping the medicine. Decisions about stopping or changing a dose belong to the prescriber or care team, not to the app or this guide.
That is also why the app will not calculate, validate, or suggest doses. It will not tell you when to taper, how fast to taper, or what to do with your medication. It is built for tracking only, with a medical disclaimer that reminds you to use your clinician's guidance.
Some people want a clear written record because instructions can be easy to forget, especially when a plan changes over time. A tracker can help you keep the details in one place without turning the app into a decision maker. For a closer look at the structure of that record, see the taper timeline feature.
If you are looking for a simple rule or a universal schedule, this is not the place. There is no one schedule here to copy, and that is intentional. Your prescriber may use different instructions depending on your situation, and this site stays out of that choice.
Who sets a taper
Your prescriber or care team sets the taper, if a taper is part of your plan. The app can help you store what they told you, but it does not decide whether tapering makes sense or how it should be done. Those decisions are clinical, and they belong with the person managing your care.
That caution matters because research shows that changes after stopping can differ a lot from changes after continuing. In the SURMOUNT 4 trial, adults who completed 36 weeks of tirzepatide and were then switched to placebo gained 14.0% of body weight from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%. A study result like that can inform discussion, but it does not replace individualized medical guidance.
Because of that, the app stays neutral. It may help you notice what was written down, what changed, and when a new instruction appeared. It does not say whether a taper should happen, whether it should continue, or whether a dose should be held, reduced, or stopped.
If your instructions are unclear, the safest next step is to ask the clinician who prescribed the medication. If eating feels hard while you are changing routines or paying close attention to food, talk to a clinician as well. This site is for tracking and education, not treatment advice.
How to record the steps you were given
The app's taper timeline is designed to mirror the instructions you already have. You enter the dose steps exactly as they were given to you, along with dates or notes if you want them. The app never calculates a dose and never fills in missing steps.
A simple way to use it is to copy the language from your visit summary, portal message, or after visit note. You can keep the wording close to the original so there is less room for confusion later. If the plan changes, you can add the new instruction as a new entry rather than overwriting the old one.
People may also use notes to record why a change was discussed, what question they still have, or when they plan to follow up. That can make future conversations easier without turning the app into a decision aid. The goal is a clean history of what your care team said, not a plan made by the app.
- Enter only the steps you were given
- Keep the original wording if it helps you remember
- Add notes for follow up questions
- Save updates as new entries if the plan changes
- Use the timeline as a record, not as instructions
The app is also planned to store data on the device, with no account, plus export and delete everything. That can make it easier to keep a private record of a taper discussion without sharing it more widely than you want.
Questions to ask
If you have a glp1 taper schedule from your prescriber and want to understand it better, it can help to bring a few clear questions to the next visit. You do not need to solve the plan alone, and you do not need to guess between appointments.
- Can you write the taper steps in plain language for me?
- What should I do if the schedule changes?
- When should I check back with you?
- Which symptoms or changes should prompt a call?
- Can you confirm the exact dose steps in writing?
If you want a place to keep those answers together, the app's taper timeline may help once it is live. You can also pair it with the app's other tracking tools, like the weekly appetite check in, strength log, and body weight based protein and fiber targets, if those fit the way your care team wants you to monitor things. None of those tools replace medical advice, and they do not tell you how to change medication.
For the full caution about what this site does and does not do, see the medical disclaimer. If you are comparing labels, notes, or visit summaries, keep the final word with your prescriber or care team.
Join the iOS waitlist from Get the app.
Key facts
- In SURMOUNT-4 (JAMA 2024), from week 36 to week 88 people switched to placebo gained 14.0% of body weight, while those who continued tirzepatide lost a further 5.5%. Source
- FDA labels for Wegovy and Zepbound do not provide a taper schedule for stopping. Source
Sources
Last updated: